Market Value150,076,000
Total Holdings50
File Date2019-11-12
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
GTHX / G1 Therapeutics, Inc.
PXD / Pioneer Natural Resources Company
EQT / EQT Corporation
ARVN / Arvinas, Inc.
VYGR / Voyager Therapeutics, Inc.
WKHS / Workhorse Group Inc.
DRNA / Dicerna Pharmaceuticals Inc
TGTX / TG Therapeutics, Inc.
MDGN / Medgenics, Inc.
MYGN / Myriad Genetics, Inc.
US26885B1008 / EQT Midstream Partners LP
AWH / Aspira Women's Health Inc.
ODT / Odonate Therapeutics Inc
MREO / Mereo BioPharma Group plc - Depositary Receipt (Common Stock)
/ Oxford Immunotec Global PLC
SLNO / Soleno Therapeutics, Inc.
DOVA / Dova Pharmaceuticals, Inc.
98235T107 / Wright Medical Group N.V.
LTHM / Livent Corporation
XBIT / XBiotech Inc.
DERM / Journey Medical Corporation
/ Array BioPharma, Inc.
ICPT / Intercept Pharmaceuticals Inc
APLS / Apellis Pharmaceuticals, Inc.
ATRA / Atara Biotherapeutics, Inc.
AMRN / Amarin Corporation plc - Depositary Receipt (Common Stock)
ECA / EnCana Corp.
CLR / Continental Resources Inc (OKLA)
ARNA / Arena Pharmaceuticals Inc
BIIB / Biogen Inc.
XLRN / Acceleron Pharma Inc
QDEL / QuidelOrtho Corporation
SIEN / Sientra, Inc.
CELG / Celgene Corp.
VNDA / Vanda Pharmaceuticals Inc.
ALBO / Albireo Pharma Inc
CFRX / ContraFect Corp
LXRX / Lexicon Pharmaceuticals, Inc.
ACAD / ACADIA Pharmaceuticals Inc.
CYTK / Cytokinetics, Incorporated
VCYT / Veracyte, Inc.
YTEN / Yield10 Bioscience, Inc.
NKTR / Nektar Therapeutics
KPTI / Karyopharm Therapeutics Inc.
IMGN / ImmunoGen, Inc.
AXDX / Accelerate Diagnostics, Inc.
KALV / KalVista Pharmaceuticals, Inc.
CORT / Corcept Therapeutics Incorporated
FOLD / Amicus Therapeutics, Inc.
BCRX / BioCryst Pharmaceuticals, Inc.
NBIX / Neurocrine Biosciences, Inc.
HROW / Harrow, Inc.
MASI / Masimo Corporation
XNCR / Xencor, Inc.
BMY / Bristol-Myers Squibb Company